BCLS Acquisition Corp.

BCLS Acquisition Corp. (Nasdaq: BLSA) is a special purpose acquisition company sponsored by Bain Capital Life Sciences, the dedicated life sciences investment arm of Bain Capital. The vehicle completed its initial public offering in October 2020, targeting acquisition opportunities in the biopharmaceutical and life sciences sector. BLSA subsequently announced a business combination with Jasper Therapeutics, a clinical-stage company focused on hematopoietic stem cell transplantation, with the merger closing in 2022 and the combined company trading under the ticker JSPR. Visit SpacDesk and sign up for full data, filings, and analytics on BLSA and hundreds of other SPAC transactions.